Evaluation of electromagnetic incompatibility concerns for deep brain stimulators

Journal of Neuroscience Nursing

Volumn 40, Issue 5, 2008, Pages

  Dustin, Kelly ^a  

^a Office of Research Protections (ORP)   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DEPTH STIMULATION; ELECTRIC INJURY; ELECTRODE; ELECTROMAGNETIC FIELD; EQUIPMENT; HUMAN; INSTRUMENTATION; MOTOR DYSFUNCTION; ORGANIZATION AND MANAGEMENT; REVIEW;

DEEP BRAIN STIMULATION; ELECTRIC INJURIES; ELECTRODES, IMPLANTED; ELECTROMAGNETIC FIELDS; EQUIPMENT FAILURE ANALYSIS; EQUIPMENT SAFETY; HUMANS; MOVEMENT DISORDERS; SECURITY MEASURES;

EID: 58149305835     PISSN: 08880395     EISSN: None     Source Type: Journal    
DOI: 10.1097/01376517-200810000-00008     Document Type: Article

References (18)

1. Association of periOperative Registered Nurses. (2005, July). AORN guidance statement: Care of the perioperative patient with an implanted electronic device. AORN Journal, 153-170.
2. Boivin, W., Coletta, J., & Kerr, L. (2003). Characterization of the magnetic fields around walk-through and hand-held metal detectors. Health Physics, 84 (5), 582-593.
3. Center for Devices and Radiological Health. (2000). Neurological Device Panel Meeting Summary. Retrieved February 17, 2006, from www.fda.gov/cdrh/ndp. html.
4. Chen, H., Hua, S., Smith, M., & Shadmehr, F. (2006). Effects of human cerebellar thalamus disruption on adaptive control of reaching. Cerebral Cortex, 16 (10), 1462-1473.
5. Hamel, W., Fietzek, U., Morsnowksi, A., Schrader, B., Herzog, J., Weinert, D., et al. (2003). Deep brain stimulation of the subthalamic nucleus in Parkinson's disease: An evaluation of active electrode contacts. Journal of Neurology, Neurosurgery, and Psychiatry, 74 (8), 1036-1046.
6. Kainz, W., Neubauer, G., Alesch, F., Schmid, G., & Jahn, O. (2001). Electromagnetic compatibility of electronic implants: Review of literature. Middle European Journal of Medicine, 113 (23-24), 903-914.
7. Medtronic, Inc. (2000). Summary of safety and effectiveness data for a supplemental pre-market approval application. Minneapolis, MN: Author.
8. Medtronic, Inc. (2006a). Important safety information and risks. Retrieved March 1, 2006, from www.medtronic.com/neuro/paintherapies/ paintreatment-ladder/neurostimulation/risks.
9. Medtronic, Inc. (2006b). Medtronic Activa Therapy: Important safety information. Retrieved March 1, 2006, from www.medtronic.com/physician/activa/ disclosure.html.
10. Paulter, N. G. (2002, November). The National Institute of Justice standards for hand-held and walk-through metal detectors used in concealed weapon and contraband detection. Gaithersburg, MD: National Institute of Standards and Technology (NISTIR Publication No. 6915).
11. Reynolds, N. C., Terry, L. C., Mark, L. P., Prieto, T. E., & Mueller, W. R. (2000). Too many treatments for Parkinson's disease: How should they be used? Wisconsin Medical Journal, 99 (3), 57-61.
12. Silberberg, J. L. (1993). Performance degradation of electronic medical devices due to electromagnetic interference. Compliance Engineering, Fall 1993, 25-39.
13. U. S. Food and Drug Administration (1999). Consumer report: Security systems may disrupt electronic devices. Retrieved February 17, 2006, from www.fda.gov/fdac/departs/1999.
14. U. S. Food and Drug Administration. (2002, January). Approval letter for P960009/S007. Rockville, MD: Author. Retrieved August 13, 2008, from www.fda.gov/cdrh/pdf/p960009s7.html.
15. U. S. Food and Drug Administration. (2006a). Manufacturer and User Facility Device Experience Database. Retrieved March 22 and 23, 2006, from www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfMAUDE/Results.
16. U. S. Food and Drug Administration. (2006b). Medical device recalls: Class 2 recall Medtronic Active Deep Brain Stimulation System (Z-0370-06). Retrieved February 15, 2006, from www.accessdata.fda.gov/scripts/cdrh/cfRES/res. cfm.
17. Vidailhet, M., Vercueil, L., Houeto, J., Krystkowiak, P., Benabid, A., Cornu, P., et al. (2005). Bilateral deep brain stimulation of the globus pallidus in primary generalized dystonia. New England Journal of Medicine, 352, 459-467.
18. Witters, D. (1995). Medical devices and EMI: The FDA perspective. Rockville, MD: U. S. Food and Drug Administration, Center for Devices and Radiological Health.